Clinical Trial Update: miRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes Prediction

View source ↗

Summary

An ongoing Chiang Mai University trial is investigating miRNA and FGF21 profiles in early pregnancy to predict gestational diabetes and is currently not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: Chiang Mai University | Conditions: Gestational Diabetes | Status: ACTIVE_NOT_RECRUITING